Last year, China Uzbekistan pharmaceutical trade reached 160 million US dollars

The export volume has increased steadily The market development prospect is optimistic that private enterprises will become the main exporters The pharmaceutical trade volume between China and Ukraine reached 160 million US dollars, an increase of 2.72% year on year Among them, the export volume of China to Ukraine is 159 million US dollars, an increase of 3.88% year on year; the import volume from the region is 1984400 US dollars, a decrease of 45.79% year on year With the increase of residents' income level, Ukrainians are gradually willing to receive TCM and acupuncture treatment In 2012, China's export of traditional Chinese medicine to Ukraine was US $1898300, up 35.68% year on year, accounting for 1.19%; the import of traditional Chinese medicine from Ukraine was US $1248800, up 164.28% year on year, accounting for 62.93% China's export of Western medicine to Ukraine amounted to US $70.3433 million, an increase of 8.38% year on year Most of them are raw materials of Western medicine, mainly amino acids and their derivatives and anti infection products, with the export volume of US $47.8772 million, up 10.61% year on year; the export volume of Western patent medicine is only US $6.9347 million, mainly cephalosporins China exports 15.5313 million US dollars of biochemical drugs to Ukraine, and the main export products are enzymes and coenzymes Ukraine mainly imports drugs from Germany, France and India, and its imported drug sales account for about 70% of the market share In, China's export of medical devices to Ukraine was US $87.1285 million, basically the same as that of the previous year, mainly including hospital diagnosis and treatment products, disposable consumables and health rehabilitation supplies The country is in urgent need of equipment for diagnosis, surgery, Radiology, laboratory, obstetrics and Gynecology and burn treatment Hospitals and outpatients need to introduce a large number of new technologies, equipment and medical supplies The market development prospect is promising The drug registration regulations of Ukraine are not completely consistent with those of the European Union, but also slightly different from those of many countries From 1996 to 2006, 2554 kinds of domestic drugs and 5068 kinds of imported drugs were registered in Ukraine Its national pharmacological center has two committees: one is the drug quality inspection and control committee, the other is the registration information review and confidential information protection committee The normal time for drug registration in Ukraine is 210 days, excluding the time for communication with the applicant or modification of documents The cost of registration of imported drugs is about $70000 to $100000 For large enterprises, these costs are not high, but considering the current economic situation in Ukraine, although the Ministry of health has set the maximum price for drug registration and re registration, there will inevitably be potential rules, so that the real registration costs and time will be increased and delayed to varying degrees The quality of API determines the quality of the drug Ukraine requires that a registration certificate is required for API purchase to ensure the quality of API In the past 5-10 years, Ukraine has not invested too much in drug research and development Its drug management system is still in the stage of reform and integration with the European Union In the future, Ukraine will become the center and bridge connecting the trade between Western Europe and Eastern European countries At the same time, these steps have strengthened the competitiveness of its own pharmaceutical industry, and the process of EU standard integration has also helped Ukraine's own drugs to be in an advantageous position in the competition with low-quality drugs Ukrainians have been looking forward to a new transformation of the Ukrainian pharmaceutical industry In 2009, the government adopted new regulations on drug production, medical treatment, inspection and operation in accordance with directive 1419 of 2004 But all the renovation, equipment purchase, new plant construction and technological innovation need a lot of money Some local enterprises have begun to invest in the transformation, which is conducive to its defeat of other competitors as soon as possible to enter the international market Looking at the development process of Ukraine's pharmaceutical industry, its pharmaceutical production, sales, registration and supervision have undergone many changes There is no doubt about its market potential, but the implementation of many policies is also restricted by the economic and political environment Its local enterprises are still trying to maintain their own position, and the strong offensive of foreign enterprises has also injected new vitality into this market The future development trend of the drug market in Ukraine will be characterized by harmonious and steady development of the drug market, mainly sales of imported drugs, further stability of the status of local drug companies and continuous rise in drug prices In the year when the private enterprises became the main exporters, 1363 enterprises owned the pharmaceutical export business to Ukraine Among them, there are 1056 private enterprises, with an export volume of US $99.1221 million, an increase of 14.27% year-on-year, accounting for 62.2% of the total export volume of all export enterprises; 179 "three capital" enterprises, with an export volume of US $43.23004 million, an increase of 1.59% year-on-year, accounting for 27.13% of the total export volume of all enterprises to Ukraine At present, China's main export provinces to Ukraine are Zhejiang, Shandong, Jiangsu and Guangdong, and the provinces with rapid export growth are Jiangsu and Sichuan China imported few medical products from Ukraine In 2012, the import volume was only US $1984400, an increase of 81.64% year-on-year, mainly Chinese herbal extracts, with the import volume of US $778600 There is potential for the export of Chinese patent medicines The Ukrainian government offers many preferential policies to its pharmaceutical enterprises, such as increasing the health care budget, purchasing international non patent drugs through budget funds, maintaining zero value-added tax and abolishing the drug customs tariff system Although the Ukrainian government has strengthened medical security measures, the overall level of medical welfare is still low In the pharmaceutical market of Ukraine, the main force is still the foreign corps, mainly the European pharmaceutical companies, and the number is increasing year by year As a national secret prescription drug, huatuozaiban has entered the Russian pharmaceutical market for a long time, and has successively entered Bulgaria, Ukraine and other European countries as a drug Although there are few Chinese patent medicines in Ukraine, Ukraine's attitude of not excluding TCM culture provides us with space for development The sale of traditional Chinese medicine in CIS countries is not limited to the Chinese community The acceptance of traditional Chinese medicine by local people and the large population are also conducive to the spread of traditional Chinese medicine culture and the sale of traditional Chinese medicine In addition, compared with Russia, Ukrainian English is widely used, which is conducive to the exchange and cooperation between Chinese and Ukrainian enterprises.